PT - JOURNAL ARTICLE AU - Watson, Daniella AU - Baralle, Natalia Laverty AU - Alagil, Jawahr AU - Anil, Krithika AU - Ciccognani, Sandy AU - Dewar-Haggart, Rachel AU - Fearn, Sarah AU - Groot, Julia AU - Knowles, Kathryn AU - Meagher, Claire AU - McGrath, Carmel AU - Muir, Sarah AU - Musgrove, Jo AU - Glyn-Owen, Kate AU - Woods-Townsend, Kath AU - Mortimore, Andrew AU - Roderick, Paul AU - Baird, Janis AU - Inskip, Hazel AU - Godfrey, Keith AU - Barker, Mary AU - , TI - How best do we engage the general population in testing for COVID-19? AID - 10.1101/2021.01.29.21250730 DP - 2021 Jan 01 TA - medRxiv PG - 2021.01.29.21250730 4099 - http://medrxiv.org/content/early/2021/02/01/2021.01.29.21250730.short 4100 - http://medrxiv.org/content/early/2021/02/01/2021.01.29.21250730.full AB - The UK Scientific Advisory Group for Emergencies (SAGE) emphasises the need for high levels of engagement with communities and individuals to ensure the effectiveness of any COVID-19 testing programme. A novel pilot health surveillance programme to assess the feasibility of weekly mass RT-LAMP testing for the SARS-CoV-2 virus using saliva samples collected at home was developed and piloted by the University of Southampton and Southampton City Council. Rapid qualitative evaluation was conducted to explore experiences of those who took part in the programme, of those who declined and of those in the educational and healthcare organisations involved in the pilot testing who were responsible for roll-out. This included 77 interviews and 20 focus groups with 223 staff, students, pupils and household members from four schools, one university, and one community healthcare NHS trust. Conversations revealed that high levels of communication, trust and convenience were necessary to ensure people’s engagement with the programme. This suggests community leaders and stakeholder organisations should be involved throughout programme development and implementation to optimise these features of the testing. Participants’ and stakeholders’ motivations, challenges and concerns need to be understood and these insights used to modify the programme in a continuous, real-time process to ensure and sustain engagement with testing over the extended period necessary.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis project was funded by the Department of Health and Social Care.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Professional Services at the University of Southampton granted Administrative Research Ethics and Quality Assurance (AREQA) approval to carry out this study. Formal ethics permission was not required for this piece of institutional research. To gain approval for participants under 18 years old, written consent was taken from parents and guardians. Formal consent was not taken for adults over 18 years old as it is not required for institutional research. All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData is available on request.